St. Jude Medical Inc. (NYSE:STJ) shares hit a new 52-week high on Tuesday . The stock traded as high as $82.18 and last traded at $82.08, with a volume of 675,142 shares. The stock had previously closed at $82.01.

A number of research analysts have recently commented on STJ shares. JPMorgan Chase & Co. reissued a “hold” rating on shares of St. Jude Medical in a report on Sunday, July 17th. Canaccord Genuity reissued a “hold” rating on shares of St. Jude Medical in a report on Saturday, April 30th. Leerink Swann reissued a “buy” rating on shares of St. Jude Medical in a report on Saturday, April 23rd. Needham & Company LLC reissued a “buy” rating and set a $75.00 price objective (up previously from $70.00) on shares of St. Jude Medical in a report on Wednesday, April 20th. Finally, Wells Fargo & Co. reissued a “hold” rating on shares of St. Jude Medical in a report on Saturday, April 30th. Twenty-two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $75.93.

The firm has a market capitalization of $23.67 billion and a PE ratio of 35.70. The firm’s 50 day moving average price is $78.71 and its 200-day moving average price is $65.21.

St. Jude Medical (NYSE:STJ) last posted its earnings results on Wednesday, July 20th. The medical technology company reported $1.06 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.06. The firm had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.55 billion. During the same period in the prior year, the business earned $1.07 EPS. St. Jude Medical’s quarterly revenue was up 10.8% compared to the same quarter last year. Equities analysts anticipate that St. Jude Medical Inc. will post $4.06 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, July 29th. Shareholders of record on Thursday, June 30th will be given a dividend of $0.31 per share. The ex-dividend date of this dividend is Tuesday, June 28th. This represents a $1.24 annualized dividend and a dividend yield of 1.51%.

Several institutional investors have recently bought and sold shares of STJ. Dimensional Fund Advisors LP boosted its position in St. Jude Medical by 32.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 823,890 shares of the medical technology company’s stock valued at $50,894,000 after buying an additional 199,858 shares in the last quarter. BNP Paribas Arbitrage SA raised its stake in shares of St. Jude Medical by 2.7% in the fourth quarter. BNP Paribas Arbitrage SA now owns 35,027 shares of the medical technology company’s stock valued at $2,164,000 after buying an additional 911 shares during the last quarter. Dorsey & Whitney Trust CO LLC raised its stake in shares of St. Jude Medical by 6.9% in the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 54,103 shares of the medical technology company’s stock valued at $3,343,000 after buying an additional 3,484 shares during the last quarter. I.G. Investment Management LTD. raised its stake in shares of St. Jude Medical by 29.7% in the fourth quarter. I.G. Investment Management LTD. now owns 228,600 shares of the medical technology company’s stock valued at $14,121,000 after buying an additional 52,300 shares during the last quarter. Finally, Advisors Asset Management Inc. raised its stake in shares of St. Jude Medical by 32.6% in the fourth quarter. Advisors Asset Management Inc. now owns 20,002 shares of the medical technology company’s stock valued at $1,236,000 after buying an additional 4,916 shares during the last quarter.

St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.